Vinay Shah
Equibles does not estimate personal net worth.
About Vinay Shah
Earlier roles on record: CFO at Azora Therapeutics, Inc. (DE) (AZR) until October 28, 2026 and CFO at Azora Therapeutics, Inc. (DE) (AZR) until August 13, 2026. Azora Therapeutics, Inc. (DE) reported in an 8-K filed October 28, 2026 that Vinay Shah was terminated as Chief Financial Officer, effective October 28, 2026. Azora Therapeutics, Inc. (DE) reported in an 8-K filed August 13, 2026 that Vinay Shah was terminated as Chief Financial Officer. Azora Therapeutics, Inc. (DE) reported in an 8-K filed November 5, 2024 that Vinay Shah was appointed Chief Financial Officer, effective November 16, 2024. The proxy statement of Azora Therapeutics, Inc. (DE) reports total compensation of $458,855 for Vinay Shah in fiscal 2025, including a base salary of $315,000. Disclosed compensation is on record for 2 fiscal years.
“In connection with Ms. Economides’ appointment as Chief Financial Officer, Ms. Economides will succeed Vinay Shah, whose employment was terminated effective as of the Effective Date.”
“the employment of its current Chief Financial Officer, Vinay Shah, will be terminated effective promptly after the 2026 Annual Meeting if Stockholder Approval is obtained”
Affiliation history
-
2024-11-16–2026-10-28
-
2024-11-16–2026-08-13
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Azora Therapeutics, Inc. (DE) (AZR) | Chief Financial Officer | $315,000 | $458,855 |
| 2024 | Azora Therapeutics, Inc. (DE) (AZR) | Chief Financial Officer | $39,375 | $91,204 |